KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bausch Health Companies (BHC) Amortization - Intangibles (2016 - 2025)

Bausch Health Companies' Amortization - Intangibles history spans 17 years, with the latest figure at $236.0 million for Q4 2025.

  • For Q4 2025, Amortization - Intangibles fell 8.88% year-over-year to $236.0 million; the TTM value through Dec 2025 reached $1.0 billion, down 7.06%, while the annual FY2025 figure was $1.0 billion, 7.06% down from the prior year.
  • Amortization - Intangibles for Q4 2025 was $236.0 million at Bausch Health Companies, down from $253.0 million in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $360.0 million in Q2 2021 and bottomed at $236.0 million in Q4 2025.
  • The 5-year median for Amortization - Intangibles is $274.0 million (2024), against an average of $287.2 million.
  • The largest annual shift saw Amortization - Intangibles fell 18.12% in 2021 before it grew 8.3% in 2024.
  • A 5-year view of Amortization - Intangibles shows it stood at $320.0 million in 2021, then decreased by 2.19% to $313.0 million in 2022, then dropped by 9.9% to $282.0 million in 2023, then dropped by 8.16% to $259.0 million in 2024, then dropped by 8.88% to $236.0 million in 2025.
  • Per Business Quant, the three most recent readings for BHC's Amortization - Intangibles are $236.0 million (Q4 2025), $253.0 million (Q3 2025), and $256.0 million (Q2 2025).